longbridge

Alterity Therapeutics

ATHE
----

All Shareholders

Shareholder Type

  • Public and others46.41%
  • Institutions32.82%
  • Hedge funds14.17%
  • Private companies3.53%
  • Others3.06%

Major Shareholders

Major Shareholders Latest
Shareholder
BNY Asset Management
25.85%59.22M0.69%+4.50M
Regal Partners Limited
14.17%32.47M0.76%+0
JPMorgan Chase & Co.
3.20%7.32M0.17%+0
Carl Charalambous
1.67%3.83M0.09%+0
Orchid Bay Investments Pty Ltd
1.34%3.07M0.50%+1.25M
One Managed Investment Funds Limited
0.98%2.25M0.44%+1.07M
David StamlerCEO, MD & Director
0.83%1.90M0.04%+1.00
Jing Yang Pty Ltd
0.81%1.85M0.04%+0
Twin Lakes Capital Management, LLC
0.73%1.67M0.04%+0
Just Group Investment Pty Ltd
0.73%1.67M--+1.67M
Norges Bank Investment Management
0.71%1.62M0.04%+1.20K
Dramista Pty Ltd
0.54%1.23M0.03%+0
Andrew Seton
0.42%962.97K0.01%+78.90K
Morgan Stanley
0.33%756.59K<0.01%+56.20K
Greenleaf Trust National Association
0.32%744.00K0.15%+360.00K
HB Wealth Management, LLC
0.31%701.52K0.02%+0
Citadel Advisors LLC
0.20%451.16K0.09%+210.24K
Peter MarksNon-Executive Independent Director
0.10%227.70K0.08%+191.34K
Hudson River Trading LLC
0.09%207.50K--+207.50K
Lampam Pty. Ltd.
0.08%191.34K--+191.34K
© 2026 Longbridge｜Terms of ServicePrivacy Policy